WO2008013900A3 - Composition d'amplification d'activité ostéogène - Google Patents
Composition d'amplification d'activité ostéogène Download PDFInfo
- Publication number
- WO2008013900A3 WO2008013900A3 PCT/US2007/016825 US2007016825W WO2008013900A3 WO 2008013900 A3 WO2008013900 A3 WO 2008013900A3 US 2007016825 W US2007016825 W US 2007016825W WO 2008013900 A3 WO2008013900 A3 WO 2008013900A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- osteogenic
- enhancer composition
- enhancer
- composition
- bone
- Prior art date
Links
- 239000003623 enhancer Substances 0.000 title abstract 2
- 230000002188 osteogenic effect Effects 0.000 title abstract 2
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 210000000845 cartilage Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0015—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/112—Phosphorus-containing compounds, e.g. phosphates, phosphonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/428—Vitamins, e.g. tocopherol, riboflavin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/43—Hormones, e.g. dexamethasone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/64—Animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Materials Engineering (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/374,475 US8101198B2 (en) | 2006-07-26 | 2007-07-25 | Osteogenic enhancer composition |
EP07836268A EP2046361A4 (fr) | 2006-07-26 | 2007-07-25 | Composition d'amplification d'activité ostéogène |
JP2009521838A JP2009544411A (ja) | 2006-07-26 | 2007-07-25 | 骨形成増進組成物 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83383106P | 2006-07-26 | 2006-07-26 | |
US60/833,831 | 2006-07-26 | ||
US88102207P | 2007-01-17 | 2007-01-17 | |
US60/881,022 | 2007-01-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008013900A2 WO2008013900A2 (fr) | 2008-01-31 |
WO2008013900A3 true WO2008013900A3 (fr) | 2008-12-04 |
Family
ID=38982079
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/016825 WO2008013900A2 (fr) | 2006-07-26 | 2007-07-25 | Composition d'amplification d'activité ostéogène |
Country Status (4)
Country | Link |
---|---|
US (1) | US8101198B2 (fr) |
EP (1) | EP2046361A4 (fr) |
JP (1) | JP2009544411A (fr) |
WO (1) | WO2008013900A2 (fr) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2442747A4 (fr) * | 2009-06-17 | 2016-11-09 | Univ Columbia | Échafaudages dentaires |
US8614190B2 (en) | 2010-06-30 | 2013-12-24 | Industrial Technology Research Institute | Thermal responsive composition for treating bone diseases |
US20120294898A1 (en) * | 2011-05-19 | 2012-11-22 | Warsaw Orthopedic, Inc. | Injectable dbm for soft tissue repair |
JP6292815B2 (ja) | 2013-10-10 | 2018-03-14 | 京セラ株式会社 | 抗酸化性人工補綴部材 |
JP2017226601A (ja) * | 2014-11-04 | 2017-12-28 | 国立大学法人 東京医科歯科大学 | 骨形成因子安定保持剤、骨形成因子活性化剤、骨形成因子の安定保持方法、及び骨形成因子の活性化方法 |
CN104784752A (zh) * | 2015-04-22 | 2015-07-22 | 山东明德生物医学工程有限公司 | 一种具有抗氧化特性的可注射性骨水泥及其制备方法和用途 |
CN105031738B (zh) * | 2015-09-09 | 2018-06-15 | 山东明德生物医学工程有限公司 | 一种低放热骨水泥及制备方法和应用 |
CN106924822B (zh) * | 2015-12-31 | 2020-02-28 | 先健科技(深圳)有限公司 | 可吸收铁基合金内固定植入医疗器械 |
RU2644724C1 (ru) * | 2017-04-18 | 2018-02-13 | Георгий Сергеевич Немов | Средство, обладающее корректирующим действием на метаболизм хрящевой ткани и способ его получения |
WO2019231763A1 (fr) | 2018-05-27 | 2019-12-05 | Christos Angeletakis | Adhésifs tissulaires et produits de scellement utilisant des aldéhydes d'origine naturelle |
JP7479709B2 (ja) * | 2019-06-19 | 2024-05-09 | 学校法人東邦大学 | バンコマイシンの骨形成阻害作用を緩和した感染症治療剤 |
KR20210153389A (ko) | 2020-06-10 | 2021-12-17 | 가톨릭대학교 산학협력단 | 노니 추출물을 유효성분으로 포함하는 줄기세포 생존능 및 골분화 개선용 조성물 |
KR20220072167A (ko) * | 2020-11-25 | 2022-06-02 | 가톨릭관동대학교산학협력단 | 연골 재생용 스캐폴드 |
CN113975468A (zh) * | 2021-11-11 | 2022-01-28 | 成都中科娥皇健康咨询有限公司 | 一种骨膜组织老化修复剂及其制备工艺 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060183778A1 (en) * | 2003-06-05 | 2006-08-17 | Kohei Miyazono | Osteogenesis-promotion enhancer and method of screening the same |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4563489A (en) * | 1984-02-10 | 1986-01-07 | University Of California | Biodegradable organic polymer delivery system for bone morphogenetic protein |
US4866082A (en) * | 1988-04-06 | 1989-09-12 | American Home Products Corporation | Inhibition of bone loss by (-)-N-[[(5-chloro-2-benzothiazolyl)thio]phenylacetyl]-L-cysteine |
US4910259A (en) * | 1988-09-26 | 1990-03-20 | Wolff & Kaaber A/S | Bone cement |
EP0432051B1 (fr) * | 1989-12-08 | 1993-06-23 | L'oreal | Composition cosmétique réductrice pour la permanente des cheveux, à base de cystéamine et/ou de son dérivé N-acétylé et d'un polymère cationique, et son utilisation dans un procédé de déformation permanente des cheveux |
US5124151A (en) * | 1990-08-07 | 1992-06-23 | Mediventures Inc. | Drug delivery by injection with thermo-irreversible gels |
US5410016A (en) * | 1990-10-15 | 1995-04-25 | Board Of Regents, The University Of Texas System | Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
PT716610E (pt) | 1993-08-26 | 2006-08-31 | Genetics Inst Llc | Proteinas morfogeneticas dos ossos de seres humanos para utilizacao em regeneracao neural |
US5385887A (en) * | 1993-09-10 | 1995-01-31 | Genetics Institute, Inc. | Formulations for delivery of osteogenic proteins |
DE4433201A1 (de) * | 1994-09-17 | 1996-03-21 | Merck Patent Gmbh | Verfahren zur Herstellung von wirkstoffhaltigen Knochenzementen |
US5817470A (en) | 1995-03-10 | 1998-10-06 | Sociedad Biotecnologica Collico Limitada | Immobilization of antigens to solid support by the mussel adhesive polyphenolic protein and the method for use therein |
JPH08257110A (ja) | 1995-03-28 | 1996-10-08 | Nikon Corp | 骨内インプラント及びその製造方法 |
AU4721696A (en) | 1996-02-29 | 1997-09-16 | T. Sam Lindholm | An osteogenic device and a method for preparing the device |
US5932299A (en) * | 1996-04-23 | 1999-08-03 | Katoot; Mohammad W. | Method for modifying the surface of an object |
US20010014667A1 (en) * | 1998-01-05 | 2001-08-16 | Chen Charles C. | Compositions with enhanced osteogenic potential, methods for making the same and therapeutic uses thereof |
EP1023910A1 (fr) * | 1999-01-29 | 2000-08-02 | Institut Straumann AG | Préparation des surfaces ostéophiles pour prothèses métalliques fixables sur les os |
US6333304B1 (en) * | 1999-04-20 | 2001-12-25 | Teresa K. Bath | Therapeutic compositions containing glucosamine, collagen and a bioflavanol for repair and maintenance of connective tissue |
JP2003500112A (ja) | 1999-05-20 | 2003-01-07 | ボストン・ユニバーシティ | 解剖学的に正確なポリマー強化生体活性人工器官 |
SE520688C2 (sv) * | 2000-04-11 | 2003-08-12 | Bone Support Ab | Ett injicerbart ersättningsmaterial för benmineral |
AU2001286996A1 (en) * | 2000-08-31 | 2002-03-13 | Chiron Corporation | Stabilized fgf formulations containing reducing agents |
MXPA03009760A (es) | 2001-04-25 | 2005-10-05 | Eidgenoessische Technische Hoc | Matrices de suministro de farmacos para mejorar la curacion de heridas. |
TWI267378B (en) * | 2001-06-08 | 2006-12-01 | Wyeth Corp | Calcium phosphate delivery vehicles for osteoinductive proteins |
CA2460843A1 (fr) | 2001-09-21 | 2003-03-27 | Stryker Corporation | Agents porogenes pour ciments orthopediques |
CN100366300C (zh) | 2001-10-11 | 2008-02-06 | 斯特劳曼控股公司 | 亲骨型植入物 |
US7700111B2 (en) * | 2002-01-17 | 2010-04-20 | The Regents Of The University Of Michigan | Auditory nerve protection and re-growth |
US20060054276A1 (en) | 2002-07-02 | 2006-03-16 | Magnus Qvist | Use of an acidic aqueous solution of a bioadhesive polyphenolic protein as an adhesive or coating |
GB0308952D0 (en) * | 2003-04-17 | 2003-05-28 | St Georges Entpr Ltd | Method |
WO2007002516A2 (fr) * | 2005-06-23 | 2007-01-04 | Spherics, Inc. | Formes de dosage ameliorees pour le traitement de troubles moteurs |
-
2007
- 2007-07-25 EP EP07836268A patent/EP2046361A4/fr not_active Withdrawn
- 2007-07-25 JP JP2009521838A patent/JP2009544411A/ja active Pending
- 2007-07-25 US US12/374,475 patent/US8101198B2/en not_active Expired - Fee Related
- 2007-07-25 WO PCT/US2007/016825 patent/WO2008013900A2/fr active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060183778A1 (en) * | 2003-06-05 | 2006-08-17 | Kohei Miyazono | Osteogenesis-promotion enhancer and method of screening the same |
Also Published As
Publication number | Publication date |
---|---|
US20090324669A1 (en) | 2009-12-31 |
WO2008013900A2 (fr) | 2008-01-31 |
JP2009544411A (ja) | 2009-12-17 |
US8101198B2 (en) | 2012-01-24 |
EP2046361A4 (fr) | 2011-06-29 |
EP2046361A2 (fr) | 2009-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008013900A3 (fr) | Composition d'amplification d'activité ostéogène | |
WO2008060361A3 (fr) | Procédés et produits de collagène pour une réparation de tissu | |
IL179442A0 (en) | Cartilage and bone repair composition | |
EP1943348A4 (fr) | Compositions, procedes et kits pour l'amplification d'acides nucleiques | |
EP1973554A4 (fr) | Procedes de reparation de cartilage | |
WO2005020800A3 (fr) | Plaques vissées | |
WO2007062188A3 (fr) | Antagonistes de l'activine-actriia et utilisations pour activer la croissance osseuse | |
AU2005210449A8 (en) | Fertilizer compositions | |
EP1941370A4 (fr) | Procede et systeme d'adressage de table de recherche | |
WO2007146232A3 (fr) | Compositions et procédés destinés à régénérer des tissus | |
WO2007019550A3 (fr) | Composition et procede pour le traitement d'affections du cartilage | |
WO2007067624A3 (fr) | Composes bioabsorbables et compositions les contenant | |
WO2005105079A3 (fr) | Nouveaux imidazoles | |
WO2006098998A3 (fr) | Procedes et compositions de modulation de l'integrite vasculaire | |
WO2006127368A3 (fr) | Methodes pour synthetiser des imidazotriazinones | |
GB0517933D0 (en) | Repair of bone defects | |
WO2008103314A3 (fr) | Procédés pour moduler une formation et une minéralisation osseuses | |
AU2005901457A0 (en) | Repair of bone defects | |
AU2005904980A0 (en) | Compositions and method | |
AU2005905891A0 (en) | Methods and compositions for modulating TBF-Beta and collagen | |
AU2005906015A0 (en) | Device for tendon or ligament repair | |
AU2005904757A0 (en) | Device for tendon or ligament repair | |
AU2005901851A0 (en) | Composting apparatus | |
AU2005900340A0 (en) | Composting apparatus | |
AU2005905099A0 (en) | Method of tissue repair III |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07836268 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12374475 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007836268 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009521838 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |